MediFind found 94 doctor with experience in Acute Respiratory Distress Syndrome (ARDS) near Baltimore, MD. Of these, 75 are Experienced, 12 are Advanced and 7 are Distinguished.
The Johns Hopkins Hospital
Dr. R. Scott Stephens is an associate professor of medicine and oncology at the Johns Hopkins University School of Medicine. He is the Director of Oncology and Bone Marrow Transplant Critical Care at Johns Hopkins Hospital and the Sidney Kimmel Comprehensive Cancer Center. His expertise is in critical care medicine, with clinical and research focus on severe acute respiratory distress syndrome (ARDS), acute respiratory failure after hematopoietic stem cell transplant, refractory circulatory shock, and extracorporeal membrane oxygenation (ECMO) for respiratory and circulatory failure. Dr. Stephens has extensive experience in the management of septic shock, neutropenic sepsis, life-threatening oncologic complications, and pulmonary embolism. In addition, he has expertise in cardiac surgical critical care, including the critical care of heart transplant, lung transplant, and ventricular assist device patients. Dr. Stephens is a highly regarded clinician and is a member of the Miller Coulson Academy of Clinical Excellence at Johns Hopkins. He is a fellow of the American Thoracic Society (ATSF) and is an active member of the Society of Critical Care Medicine, the Extracorporeal Life Support Organization, and the American Physiologic Society. Dr. Stephens is rated as a Distinguished provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Infant Respiratory Distress Syndrome, COVID-19, and Gastrostomy.
The Johns Hopkins Hospital
Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Lung Transplant, and Embolectomy.
The Johns Hopkins Hospital
Roy Brower is a Professor of Medicine at Johns Hopkins University and was Medical Director of the Medical Intensive Care Unit at Johns Hopkins Hospital for over 30 years. He obtained his M.D. degree and completed his residency and fellowship in Pulmonary and Critical Care Medicine at Johns Hopkins. Brower’s earlier research explored mechanisms of cardiopulmonary interactions and pulmonary circulation physiology. He subsequently focused research efforts in the clinical venue. Brower has led four multicenter clinical trials of lung-protective mechanical ventilation strategies in patients with the acute respiratory distress syndrome (ARDS). One of these trials demonstrated substantially improved clinical outcomes in ARDS patients who received mechanical ventilation with lower tidal volumes. Brower was a member of the NIH ARDS Network from its inception in 1994. He was the Chair of the Steering Committee of the NIH Prevention and Early Treatment of Acute Lung Injury (PETAL) Network from 2014 to 2023. Brower has been actively involved in the American Thoracic Society. He served on the Program Committee of the Pulmonary Circulation Assembly and chaired the ATS Critical Care Assembly Planning Committee for two years. He served as chair of the Critical Care Assembly from 2003-2005 and is the recipient of the Critical Care Lifetime Achievement Award. Brower chaired the ATS Publications Policy Committee from 2012 to 2016 and twice received the ATS Presidential Citation. Brower is an accomplished clinical educator. The Johns Hopkins Osler Medical Residency Program awarded him its annual award for outstanding teaching twice, in 1996 and in 2015. The Johns Hopkins Pulmonary and Critical Care Medicine Fellowship program awarded him its annual Fellows Teaching Award in 2009. As the former Medical Director of the Medical Intensive Care Unit at Johns Hopkins Hospital, Brower focused the energy of the critical care staff to develop rigorous, evidence-based protocols and practice guidelines. He promotes standardization of care with good protocols because they help to reduce medical errors, improve the clinical research environment, and serve as effective teaching tools. Dr. Brower is rated as a Distinguished provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Acute Interstitial Pneumonia, Lung Transplant, and Gastrostomy.
The Johns Hopkins Hospital
Theodore Iwashyna is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Iwashyna is rated as a Distinguished provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), Cerebral Hypoxia, and COVID-19.
Office
Carl Shanholtz is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Shanholtz is rated as a Distinguished provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, COVID-19, Endoscopy, and Gastrostomy.
Office
Sarina Sahetya is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Sahetya is rated as a Distinguished provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). Her top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Respiratory Acidosis, COVID-19, and Severe Acute Respiratory Syndrome (SARS).
Johns Hopkins Outpatient Center
Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Advanced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.
The Johns Hopkins Hospital
Dr. Chad H. Hochberg is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University. Dr. Hochberg earned his M.D. at the University of Chicago after which he came to Johns Hopkins and completed an internal medicine residency and fellowship in Pulmonary and Critical Care Medicine. During this time Dr. Hochberg served as an Assistant Chief of Service for the Osler Training program, and earned a Masters in Clinical Research from the Johns Hopkins Bloomberg School of Public Health. As a clinician scientist, Dr. Hochberg is engaged in an active practice as an intensivist across intensive care units in the Johns Hopkins Health System. He connects this clinical experience with a research agenda that uses tools from implementation science and health informatics to broaden adoption and foster optimization of evidence-based interventions for patients suffering from critical illness. Dr. Hochberg is rated as an Advanced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Ocular Hypertension (OHT), and Severe Acute Respiratory Syndrome (SARS).
The Johns Hopkins Hospital
Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as an Advanced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Acute Respiratory Distress Syndrome (ARDS), and Cerebral Hypoxia.
The Johns Hopkins Hospital
Dr. Checkley specializes in intensive care medicine. He is an expert in the diagnosis and management of acute respiratory failure and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions commonly seen in the medical intensive care unit, including septic shock, acute gastrointestinal bleeding, acute liver failure, among other critical conditions. Dr. Checkley earned his M.D. from Northwestern University and received his Ph.D. from Johns Hopkins University. He completed his internal medicine residency training at Emory University and fellowship training in pulmonary and critical care medicine at Johns Hopkins School of Medicine. His research interests include International lung health, epidemiology, mechanical ventilation and acute lung injury. Dr. Checkley has been recognized by the National Institute of Health with the 2007 Post-doctoral National Research Service Award and the 2009 Pathway to Independence Career Award. Dr. Checkley is rated as an Advanced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Cerebral Hypoxia.
Johns Hopkins Outpatient Center
Dr. Kolb is a specialist in Pulmonary and Critical Care Medicine with special focus on pulmonary vascular disease and Critical Care Medicine. He is an expert in the diagnosis and management of all forms of chronic pulmonary hypertension, and has special interests in the chronic thromboembolic pulmonary hypertension, peri-operative and ICU management of pulmonary hypertension. He is an expert in the management of acute pulmonary embolism, leads the Johns Hopkins Pulmonary Embolism Response Team, and provides longitudinal ambulatory follow-up for patients after acute pulmonary embolism. He has extensive experience in the diagnosis and management of all forms of acute respiratory failure and other life-threatening conditions such as shock, gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis and hyperosmolar states, and acute kidney and liver failure. Dr. Kolb is rated as an Experienced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.
Johns Hopkins Outpatient Center
Errol L. Bush, M.D., FACS, is a thoracic surgeon and surgical director of the Advanced Lung Disease and Lung Transplant Program for the Johns Hopkins Comprehensive Transplant Center. He also serves as director of the Ex vivo Lung Perfusion Program (EVLP). Dr. Bush specializes in the surgical treatment of chronic and end stage lung diseases, as well as benign (non-cancerous) and malignant (cancerous) diseases and lesions of the chest. He is skilled in minimally invasive operations such as video-assisted thoracoscopic surgery (VATS), a type of thoracic surgery performed using a small video camera that is introduced into the patient's chest via a scope to treat lung and esophageal cancers. Dr. Bush also has experience with extracorporeal membrane oxygenation (ECMO), a technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs can no longer serve their function. His research interests include investigations of outcomes and health disparities related to lung cancer, lung transplant and ECMO patients. Dr. Bush is currently leading several open clinical trials. Dr. Bush is rated as an Experienced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Lung Cancer, Pulmonary Fibrosis, Fibrosing Mediastinitis, Lung Transplant, and Heart Transplant.
Johns Hopkins Outpatient Center
Dr. Merlo is an internist who specializes in pulmonary and critical care medicine. Dr. Merlo also has clinical expertise in the care of patients with cystic fibrosis as well as clinical expertise in the care of patients with advanced lung disease who may require or have undergone lung transplantation. Dr. Merlo holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Merlo attended the College of the Holy Cross and completed medical school and residency training in internal medicine at Georgetown University. He completed both clinical and research fellowships in pulmonary and critical care medicine at Johns Hopkins, and earned his M.P.H. at the Bloomberg School of Public Health. His research interests include outcomes in lung transplantation and cystic fibrosis, HIV-related pulmonary disease, and outcomes in Osler Weber Rendu. Dr. Merlo serves as the Associate Program Director of Scholarship for the Osler Medical Housestaff Training Program. He has contributed numerous scientific papers and book chapters related to cystic fibrosis and lung transplantation, and his awards include the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation. Dr. Merlo is rated as an Experienced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Aspergillosis, Lung Transplant, and Endoscopy.
Johns Hopkins Outpatient Center
Dr. Ghoreishi is an internationally recognized expert. He brings exceptional skill in open and endovascular aortic repair, including aortic valve repair, Ross operation, valve sparing aortic root repair, innovation in minimally invasive techniques for aortic aneurysm repair, endovascular repair of high risk patients with acute type A or type B aortic dissection, and first-in-human procedures such as the Endo-Bentall repair for aortic dissection. His clinical leadership and innovation have drawn national and international referrals and advanced standards of care in this challenging field. Dr. Ghoreishi has served as Principal Investigator on several federally funded studies through the National Heart, Lung, and Blood Institute (NHLBI) and is a frequent contributor to national guidelines and surgical education symposia. Dr. Ghoreishi is rated as an Experienced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Aortic Dissection, Cystic Medial Necrosis of Aorta, Thoracic Aortic Aneurysm, Embolectomy, and Heart Bypass Surgery.
Office
Jeffrey Hasday is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Hasday is rated as an Advanced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Cerebral Hypoxia, Acute Interstitial Pneumonia, and Adenoidectomy.
Office
Giora Netzer is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Netzer is rated as an Advanced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). Her top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), and Pneumonia.
Shock Trauma Associates PA
Nader Habashi is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Habashi is rated as a Distinguished provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Hypovolemic Shock, and Bronchogenic Cyst.
University Of Maryland Pediatric Associates PA
Thomas Scalea is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Scalea is rated as an Advanced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Necrotizing Fasciitis, Delirium, Low Blood Pressure, Fasciotomy, and Splenectomy.
University Of Maryland Pediatric Associates PA
Andrea Levine is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Levine is rated as an Advanced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Pulmonary Hypertension, and Endoscopy.
The Johns Hopkins Hospital
Glenn Whitman, M.D., joined the Johns Hopkins Division of Cardiac Surgery in 2009 as associate professor of surgery. His training began at the University of Pennsylvania, where he was a resident in surgery from 1979 to 1984. He then finished his general surgery training and then completed his training as a cardiothoracic surgeon at the University of Colorado. Thereafter, Dr. Whitman became an assistant professor at the University of Colorado and chief of cardiothoracic surgery at the Denver Veteran’s Administration Hospital, where he remained for two years. In 1990, he returned to his home city of Philadelphia, where he became chief of cardiac surgery at the Medical College of Pennsylvania, formerly Women’s Medical College, the first medical school in the United States to accept women. Dr. Whitman remained there for eight years before moving to the University of Maryland as chief of cardiac surgery. He has served as the director of transplantation and United Network for Organ Sharing representative at Temple University Hospital in Philadelphia, as well as its director of perioperative services, managing preadmission testing, the operating room, and the post-anesthesia care unit. In 2007, he left Temple for Thomas Jefferson Hospital, taking over the responsibilities of running the cardiac surgery intensive care unit. In summer 2009, he was returned to Baltimore to run the cardiac surgery intensive care unit and oversee the performance improvement/quality assurance program for cardiac surgery at Johns Hopkins. Dr. Whitman’s initial research interests were in cardiac ischemia-reperfusion injury and P31 nuclear magnetic resonance of cardiac bioenergetics, for which he received both National Institutes of Health and Department of Veterans Affairs funding. He has since become involved with quality outcome, and has presented at the American College of Surgeons and the Society of Thoracic Surgeons on the difficulties associated with performance improvement and quality assurance in the field of health care, particularly in the ICU. This past year, Dr. Whitman has stepped down from his role as the Chair of the Society of Thoracic Surgery Workforce on Critical Care, a role he had held since 2014. He continues to participate in the content of the Annual Meetings for the Society of Thoracic Surgery, The American Association of Thoracic Surgery, and The STS Fall Critical Care meetings as the Programmatic Co-Chair for Perioperative Care. This past year he has participated in two major consensus statements on postcardiotomy shock (see below) and low ejection fraction CABG patients (awaiting review). 2020 EACTS/ELSO/STS/AATS ExpertConsensus on Post-CardiotomyExtracorporeal Life Support in Adult Patients Ann Thorac Surg 2012;111:327-69. Dr. Whitman is rated as an Experienced provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). His top areas of expertise are Cardiogenic Shock, Restrictive Cardiomyopathy (RCM), Hemolysis, Heart Bypass Surgery, and Heart Transplant.
Last Updated: 01/09/2026












